CSPC Pharmaceutical Group financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
HK$2.45B | HK$3.19B | HK$3.54B | HK$4.99B | HK$6.83B | HK$7.03B | HK$7.77B | HK$2.41B | HK$4.15B | HK$9.95B | HK$10.96B | HK$11.39B | HK$12.37B | HK$15.46B | HK$17.72B | HK$22.10B | HK$24.94B | HK$27.87B | HK$30.94B | HK$0.00M | HK$0.00M |
| GM % | Gross Margin % |
|
25.74% | 21.73% | 17.33% | 30.81% | 33.40% | 32.24% | 29.24% | 43.07% | 43.54% | 31.49% | 38.22% | 45.82% | 51.00% | 60.44% | 66.25% | 71.98% | 74.91% | 75.84% | 71.94% | 0.00% | 0.00% |
| OM | Operating Margin |
|
10.55% | 6.17% | 2.85% | 13.78% | 18.80% | 16.81% | 14.02% | 18.38% | 18.36% | 11.98% | 15.25% | 19.07% | 21.48% | 22.72% | 20.23% | 20.10% | 21.71% | 22.43% | 21.85% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
HK$0.05 | HK$0.01 | HK$0.18 | HK$0.32 | HK$0.33 | HK$0.26 | HK$0.08 | HK$0.08 | HK$0.08 | HK$0.11 | HK$0.15 | HK$0.18 | HK$0.24 | HK$0.30 | HK$0.34 | HK$0.52 | HK$0.56 | HK$0.58 | HK$0.56 | HK$0.00 | |
| Div. | Dividends |
|
HK$0.00 | HK$0.00 | HK$0.00 | HK$0.03 | HK$0.10 | HK$0.13 | HK$0.13 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.05 | HK$0.06 | HK$0.06 | HK$0.08 | HK$0.09 | HK$0.10 | HK$0.13 | HK$0.18 | HK$0.21 | HK$0.21 | HK$0.00 |
| PR % | Payout Ratio % |
|
0.00% | 0.00% | 0.00% | 16.67% | 31.25% | 39.39% | 50.00% | 0.00% | 0.00% | 50.00% | 45.45% | 40.00% | 33.33% | 33.33% | 30.00% | 29.41% | 25.00% | 32.14% | 36.21% | 37.50% | 0 |
| Sha. | Shares |
|
1845.75m | 1845.75m | 1845.75m | 1845.75m | 1841.95m | 1841.95m | 1841.95m | 1835.72m | 3270.51m | 6703.63m | 7089.62m | 7093.22m | 7263.02m | 7491.62m | 7483.61m | 7483.61m | 7471.61m | 11916.37m | 11913.02m | 11848.76m | 0m |
| OCF | Operating Cash Flow |
|
HK$477.10M | HK$186.91M | HK$230.82M | HK$899.49M | HK$1.52B | HK$1.57B | HK$931.45M | HK$285.63M | HK$498.08M | HK$814.86M | HK$1.81B | HK$2.25B | HK$2.92B | HK$3.29B | HK$3.80B | HK$3.78B | HK$6.74B | HK$4.64B | HK$7.63B | HK$0.00M | HK$0.00M |
| FCF | Free Cash Flow |
|
HK$-645.13M | HK$-234.26M | HK$-105.18M | HK$297.16M | HK$1.15B | HK$876.17M | HK$183.99M | HK$-6.73M | HK$293.88M | HK$217.75M | HK$999.46M | HK$1.33B | HK$1.78B | HK$2.11B | HK$2.48B | HK$2.09B | HK$6.40B | HK$3.79B | HK$6.13B | HK$5.79B | HK$0.00M |
| FCFS | Free Cash Flow Per Share |
|
HK$-0.36 | HK$-0.13 | HK$-0.06 | HK$0.14 | HK$0.60 | HK$0.46 | HK$0.06 | HK$-0.01 | HK$0.16 | HK$0.03 | HK$0.14 | HK$0.20 | HK$0.25 | HK$0.28 | HK$0.26 | HK$0.15 | HK$0.45 | HK$0.24 | HK$0.41 | HK$0.00 | HK$0.00 |